Taken together, our in vitro and in vivo data using miR-155–KO tumor cells further confirms the antitumor role of endogenous miR-155 in regulating antitumor immune response by targeting SOCS1 and altering its downstream p-STAT1/p-STAT3 balance. Here, STAT3 is linked to neoplasm.